BAY-3771249 drug page Clinical trials

Trials with BAY-3771249

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
10Countries
130Planned patients

Showing 1–1 of 1

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Recruiting Phase 1 130 patients NCT07535112

Researchers are looking for a better way to treat people who have advanced or metastatic colorectal cancer (CRC) with a specific mutation, the G12D mutation, in a protein called KRAS. Colorectal cancer (CRC) is a common type of cancer tha…

United States, Australia, Belgium, Denmark and 6 more Apr 2026 – Jul 2030 Interventional
Combined with: Cetuximab

Where the recruiting trials are